{"title":"关于西他列汀+二甲双胍固定剂量组合和伏格列波糖+格列美脲+二甲双胍三联药物组合在印度2型糖尿病治疗中的专家意见","authors":"Dr. Manjula S, Krishna Kumar M","doi":"10.33545/26649284.2024.v6.i1a.6","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":107268,"journal":{"name":"International Journal of Endocrinology Sciences","volume":"9 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Expert opinion on fixed-dose combinations of Sitagliptin + metformin and the triple drug combination of Voglibose + Glimepiride + Metformin in the management of type 2 diabetes mellitus in Indian settings\",\"authors\":\"Dr. Manjula S, Krishna Kumar M\",\"doi\":\"10.33545/26649284.2024.v6.i1a.6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":107268,\"journal\":{\"name\":\"International Journal of Endocrinology Sciences\",\"volume\":\"9 6\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Endocrinology Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33545/26649284.2024.v6.i1a.6\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Endocrinology Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33545/26649284.2024.v6.i1a.6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Expert opinion on fixed-dose combinations of Sitagliptin + metformin and the triple drug combination of Voglibose + Glimepiride + Metformin in the management of type 2 diabetes mellitus in Indian settings